These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes. Matsuda S; Keiser K; Nair JK; Charisse K; Manoharan RM; Kretschmer P; Peng CG; V Kel'in A; Kandasamy P; Willoughby JL; Liebow A; Querbes W; Yucius K; Nguyen T; Milstein S; Maier MA; Rajeev KG; Manoharan M ACS Chem Biol; 2015 May; 10(5):1181-7. PubMed ID: 25730476 [TBL] [Abstract][Full Text] [Related]
5. Application of improved GalNAc conjugation in development of cost-effective siRNA therapies targeting cardiovascular diseases. Li Q; Yin K; Ma HP; Liu HH; Li S; Luo X; Hu R; Zhang WW; Lv ZS; Niu XL; Gu MH; Li CL; Liu YS; Liu YJ; Li HB; Li N; Li C; Gu WW; Li JJ Mol Ther; 2024 Mar; 32(3):637-645. PubMed ID: 38204163 [TBL] [Abstract][Full Text] [Related]
7. Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency 10-fold in mice. Prakash TP; Graham MJ; Yu J; Carty R; Low A; Chappell A; Schmidt K; Zhao C; Aghajan M; Murray HF; Riney S; Booten SL; Murray SF; Gaus H; Crosby J; Lima WF; Guo S; Monia BP; Swayze EE; Seth PP Nucleic Acids Res; 2014 Jul; 42(13):8796-807. PubMed ID: 24992960 [TBL] [Abstract][Full Text] [Related]
8. Identification of GalNAc-Conjugated Antisense Oligonucleotide Metabolites Using an Untargeted and Generic Approach Based on High Resolution Mass Spectrometry. Husser C; Brink A; Zell M; Müller MB; Koller E; Schadt S Anal Chem; 2017 Jun; 89(12):6821-6826. PubMed ID: 28520401 [TBL] [Abstract][Full Text] [Related]
16. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing. Nair JK; Willoughby JL; Chan A; Charisse K; Alam MR; Wang Q; Hoekstra M; Kandasamy P; Kel'in AV; Milstein S; Taneja N; O'Shea J; Shaikh S; Zhang L; van der Sluis RJ; Jung ME; Akinc A; Hutabarat R; Kuchimanchi S; Fitzgerald K; Zimmermann T; van Berkel TJ; Maier MA; Rajeev KG; Manoharan M J Am Chem Soc; 2014 Dec; 136(49):16958-61. PubMed ID: 25434769 [TBL] [Abstract][Full Text] [Related]
17. Differential Uptake of Antisense Oligonucleotides in Mouse Hepatocytes and Macrophages Revealed by Simultaneous Two-Photon Excited Fluorescence and Coherent Raman Imaging. Mukherjee P; Aksamitiene E; Alex A; Shi J; Bera K; Zhang C; Spillman DR; Marjanovic M; Fazio M; Seth PP; Frazier K; Hood SR; Boppart SA Nucleic Acid Ther; 2022 Jun; 32(3):163-176. PubMed ID: 34797690 [TBL] [Abstract][Full Text] [Related]
18. Serial incorporation of a monovalent GalNAc phosphoramidite unit into hepatocyte-targeting antisense oligonucleotides. Yamamoto T; Sawamura M; Wada F; Harada-Shiba M; Obika S Bioorg Med Chem; 2016 Jan; 24(1):26-32. PubMed ID: 26678173 [TBL] [Abstract][Full Text] [Related]
19. Clinical Proof of Concept for a Novel Hepatocyte-Targeting GalNAc-siRNA Conjugate. Zimmermann TS; Karsten V; Chan A; Chiesa J; Boyce M; Bettencourt BR; Hutabarat R; Nochur S; Vaishnaw A; Gollob J Mol Ther; 2017 Jan; 25(1):71-78. PubMed ID: 28129130 [TBL] [Abstract][Full Text] [Related]
20. Exposure to siRNA-GalNAc Conjugates in Systems of the Standard Test Battery for Genotoxicity. Janas MM; Jiang Y; Duncan RG; Hayes AN; Liu J; Kasperkovitz PV; Placke ME; Barros SA Nucleic Acid Ther; 2016 Dec; 26(6):363-371. PubMed ID: 27387336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]